Search

everythinglearnresearchcommunity

for

Search:↓

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

Researchers found that dissecting folliculitis of the scalp is linked to obesity, severity increases with duration and number of nodules, and early treatment is important to prevent scarring.

Clindamycin and rifampicin are the most effective treatments for folliculitis decalvans, but more research is needed.

Erosive pustular dermatosis of the scalp is a type of skin inflammation often confused with other conditions, requiring continuous treatment.

EGFR deficiency causes significant changes in skin cells and hair follicles.

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

Oral isotretinoin, especially at higher doses for at least 3 months, is effective for treating folliculitis decalvans.

A man developed a rare scalp disorder, Folliculitis Decalvans, 20 years after hair restoration surgery, and it required long-term antibiotic treatment.

Folliculitis Decalvans and Frontal Fibrosing Alopecia can coexist in people with darker skin, showing features of both conditions.

Tigers had a skin condition causing hair loss and inflammation, but the cause is unknown and treatment didn't work.

More research, better treatments, and public education are needed for dermatological conditions in people of African descent.

The most common causes of hair loss in a Nigerian hospital were discoid lupus erythematosus of the scalp and alopecia areata, and more research is needed to understand and address these issues.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Different races and genders have unique skin and hair issues, requiring specialized care and more research for effective treatment.

Inflammation and fibrosis are important factors in hair loss, but more research with better control samples is needed.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

Facial hair transplants are generally successful, with hair growth beginning around 3 months post-surgery.

Transverse scalp biopsy sections help diagnose different alopecias by showing hair follicle details and inflammation patterns.

People with HIV and low T cell counts have more hair and scalp problems.

The machine learning model accurately detected hair loss and scalp diseases using processed images.

Videodermoscopy improves diagnosis of hair and scalp disorders and may reduce scalp biopsies.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

Malassezia infection may cause refractory acne, and antifungal treatments can help.